文献速递围术期管理与 ERAS急腹症与外科感染

围术期COVID-19感染对手术结局及ACS NSQIP质量评估风险调整的影响

Influence of Perioperative COVID-19 Infection on Surgical Outcomes and Risk Adjustment for Quality Assessment in the American College of Surgeons NSQIP.
PubMed 文献 · J Am Coll Surg · 2023-04-12

基于ACS NSQIP 2020年4月至2021年3月793,280例手术患者数据,术前COVID-19占0.66%、术后占0.58%。术后COVID-19与不良事件增加相关,死亡率从1.07%升至6.37%、肺炎从0.92%升至13.57%。将COVID-19纳入风险调整模型对手术质量评估影响甚微。

要点

  • 术后COVID-19患者死亡率近6倍增加(1.07%至6.37%)。
  • 术后COVID-19患者肺炎近15倍增加(0.92%至13.57%)。
  • 将COVID-19纳入风险调整对质量评估影响甚微。

核心结论

  • 围术期COVID-19与不良事件大幅增加相关,但医院层面质量基准评估受影响较小。
  • 尚缺乏充分证据支持因COVID-19大流行的时间有限效应而重构ACS NSQIP风险调整。

研究设计与样本

  • 回顾性队列研究,纳入ACS NSQIP 2020年4月1日至2021年3月31日793,280例患者记录。
  • 构建预测30天死亡率、并发症、肺炎、呼吸机依赖>48小时及非计划插管的模型。

主要发现

  • 术前COVID-19 5,878例(0.66%),术后COVID-19 5,215例(0.58%)。
  • 术后COVID-19与不良事件增加始终相关:死亡率从1.07%升至6.37%,肺炎从0.92%升至13.57%(排除COVID-19诊断本身)。
  • 术前COVID-19的效应较不一致。
  • 各医院COVID-19发生率有一定一致性:术前中位0.84%(IQR 0.14%–0.84%),术后中位0.50%(IQR 0.24%–0.78%)。

临床怎么用

  • 围术期应重视COVID-19状态对术后不良事件风险的显著影响。
  • 当前ACS NSQIP质量评估中纳入COVID-19风险调整对基准影响有限,暂无需重构。

局限性

  • COVID-19总体发生率较低,可能限制质量评估中检测到差异的能力。
  • 观察期内各医院发生率分布较均衡,可能削弱风险调整的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical patients with perioperative coronavirus disease 19 (COVID-19) infection experience higher rates of adverse events than those without COVID-19, which may lead to imprecision in hospital-level quality assessment. Our objectives were to quantify differences in COVID-19-associated adverse events in a large national sample and examine distortions in surgical quality benchmarking if COVID-19 status is not considered. STUDY DESIGN: Data included 793,280 patient records from the American College of Surgeons NSQIP from April 1, 2020, to March 31, 2021. Models predicting 30-day mortality, morbidity, pneumonia, and ventilator dependency greater than 48 hours, and unplanned intubation were constructed. Risk adjustment variables were selected for these models from standard NSQIP predictors and perioperative COVID-19 status. RESULTS: A total of 5,878 (0.66%) had preoperative COVID-19, and 5,215 (0.58%) had postoperative COVID-19. COVID-19 rates demonstrated some consistency across hospitals (median preoperative 0.84%, interquartile range 0.14% to 0.84%; median postoperative 0.50%, interquartile range 0.24% to 0.78%). Postoperative COVID-19 was always associated with increased adverse events. For postoperative COVID-19 among all cases, there was nearly a 6-fold increase in mortality (1.07% to 6.37%) and15-fold increase in pneumonia (0.92% to 13.57%), excluding the diagnosis of COVID-19 itself. The effects of preoperative COVID-19 were less consistent. Inclusion of COVID-19 in risk-adjustment models had minimal effects on surgical quality assessments. CONCLUSIONS: Perioperative COVID-19 was associated with a dramatic increase in adverse events. However, quality benchmarking was minimally affected. This may be the result of low overall COVID-19 rates or balance in rates established across hospitals during the 1-year observational period. There remains limited evidence for restructuring ACS NSQIP risk-adjustment for the time-limited effects of the COVID-19 pandemic.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Peters XD, Cohen ME, Meng X, et al. Influence of Perioperative COVID-19 Infection on Surgical Outcomes and Risk Adjustment for Quality Assessment in the American College of Surgeons NSQIP. J Am Coll Surg. 2023. PMID: 37042523. doi:10.1097/XCS.0000000000000711

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。